触发点注射后气胸：一例病例报告及文献综述
Pneumothorax after trigger point injection: A case report and review of literature.
作者信息
Ahiskalioglu Elif Oral, Alici Haci Ahmet, Dostbil Aysenur, Celik Mine, Ahiskalioglu Ali, Aksoy Mehmet
机构信息
Department of Anesthesiology and Reanimation, Regional Training and Research Hospital, Erzurum, Turkey.
Department of Anesthesiology and Reanimation, Ataturk University School of Medicine, Erzurum, Turkey.
出版信息
J Back Musculoskelet Rehabil. 2016 Nov 21;29(4):895-897. doi: 10.3233/BMR-160666.
BACKGROUND
Myofascial pain syndrome is defined as ``pain and/or autonomic phenomena referred from active myofascial trigger points''. Trigger point injection is an effective treatment option, which is widely used to treat myofascial pain. Trigger point injection in the cervicothoracic regions can be associated with pneumothorax.
CASE
In this paper, we presented a patient who developed pneumothorax after trigger point injection.
RESULT
This case report indicates there is a risk of pneumothorax during trigger point injection in the cervicothoracic regions.
背景
肌筋膜疼痛综合征被定义为“源自活跃肌筋膜触发点的疼痛和/或自主神经现象”。触发点注射是一种有效的治疗选择，广泛用于治疗肌筋膜疼痛。颈胸区域的触发点注射可能与气胸相关。
病例
在本文中，我们报告了一名在触发点注射后发生气胸的患者。
结果
本病例报告表明，颈胸区域触发点注射期间存在气胸风险。
Zotero 插件